Group 1 - Alan Brochstein is a pioneer in the cannabis investment sector, starting his career in the securities industry in 1986 and founding AB Analytical Services in 2007 to provide consulting for investment advisors [1] - He has been managing the investing group 420 Investor since 2013, focusing on publicly-traded cannabis stocks and providing detailed analysis and investment news [2] - The 420 Investor group includes features such as a model portfolio, weekly video analyses, summary pieces, a monthly newsletter, and a chat for investor inquiries [2] Group 2 - Alan Brochstein is also the managing partner of New Cannabis Ventures, which has been a key provider of financial information in the cannabis industry since 2015 [1] - The investing group closely monitors 20 cannabis stocks, offering previews and analyses of their earnings reports as they are released [2] - The group transitioned to Seeking Alpha in 2023, indicating a shift in its platform for reaching investors [2]

Core Insights - Aurora Cannabis (ACB) shares have increased by 21% year to date, outperforming the industry average of 5% [1][3] Company Performance - For the first quarter of fiscal 2026, Aurora's total revenues rose by 17% year over year and 8% sequentially to C$98 million, driven primarily by the medical cannabis segment [4][7] - Medical cannabis sales increased by 37% year over year to nearly C$65 million, supported by higher revenues from insurance-covered and self-paying patients in Canada, as well as growth in international markets such as Australia, Germany, Poland, and the UK [5][6] - The adjusted gross margin for the medical cannabis segment improved to 69%, up from 67% in the previous year, contributing to a 209% year-over-year increase in adjusted EBITDA to approximately C$11 million and generating free cash flow of over C$9 million, a 42% increase year over year [6][7] Market Outlook - Aurora anticipates continued growth in international medical cannabis sales in the fiscal second quarter, aided by new product launches and market expansion efforts [7][8] - The global medical cannabis market is projected to exceed $130 billion by the end of 2032, highlighting Aurora's strategic focus on this high-margin segment [8] Competitive Landscape - Despite strong performance in the medical cannabis sector, Aurora's recreational segment is underperforming due to intense competition and price pressures in Canada's adult-use market [9][10] - The company is shifting its strategy to prioritize the production of GMP-certified medical cannabis products, which offer higher margins and align with its long-term goals [10] - Aurora faces significant competition from peers like Curaleaf Holdings and Tilray Brands, both of which are also pursuing international expansion and cost optimization strategies [11][12] Valuation Estimates - Loss per share estimates for 2025 and 2026 have remained unchanged over the last 30 days, indicating stability in expectations [13] Investment Considerations - While there are positive trends in Aurora's medical cannabis division, challenges remain due to ongoing weakness in the recreational segment and a competitive market environment [15][16] - The company's cash flow is improving but remains modest compared to its investment needs, and its limited presence in the U.S. market restricts its ability to capitalize on potential federal reforms [16]

Core Insights - Herbal Dispatch Inc. is experiencing significant growth opportunities due to the ongoing BCGEU strike, which has disrupted central distribution operations at the BC Liquor Distribution Branch, leading retailers to rely on independent wholesalers and direct delivery programs [1][2] Group 1: Market Impact - The LDB typically distributes around $50 million in cannabis to BC dispensaries each month, and the closure of these distribution centers has resulted in a substantial increase in order volumes for Herbal Dispatch as retailers seek to maintain inventory [2] - Prior to the strike, Herbal Dispatch held a 35% share of BC's direct delivery market, and with the LDB's central distribution offline, the company is capitalizing on increased demand, enhancing its market penetration [3] Group 2: Strategic Advantages - Herbal Dispatch's scalable e-commerce platform and strong relationships with local producers enable efficient direct-to-retailer fulfillment, ensuring dispensaries remain well-stocked during the disruption [3] - The company anticipates that the strengthened partnerships with retailers during this period will foster long-term loyalty and drive sustained growth in its direct delivery operations, enhancing market leadership and shareholder value [4] Group 3: Commitment to Retailers - Herbal Dispatch remains dedicated to supporting BC's cannabis retailers and will continue to monitor the situation closely, providing updates as developments unfold [5]

Core Viewpoint - TerrAscend Corp. has rescheduled its earnings conference call for Q3 2025 results to November 6, 2025, at 8:30 a.m. Eastern Time due to a scheduling conflict [1]. Group 1: Conference Call Details - The earnings conference call will take place on Thursday, November 6, 2025, at 8:30 a.m. Eastern Time [2]. - A webcast of the call will be available at https://app.webinar.net/6dvVkb2k4bz [2]. - The dial-in number for the call is 1-888-510-2154, with a replay available until midnight Eastern Time on November 20, 2025 [2]. Group 2: Company Overview - TerrAscend is a leading cannabis company listed on the TSX, with operations in Pennsylvania, New Jersey, Maryland, Ohio, and California [2]. - The company operates retail locations such as The Apothecarium and has scaled cultivation, processing, and manufacturing facilities [2]. - TerrAscend offers a diverse product selection for both medical and legal adult-use markets, owning or licensing several brands including Cookies, Lemonnade, and Wana [2].

Core Insights - Village Farms International, Inc. has launched an innovative one-way aroma valve in its Pure Sunfarms brand packaging, allowing consumers to smell the cannabis flower before purchase, marking a first in Canada [1][2][3] Company Overview - Village Farms is a large-scale, vertically-integrated supplier of plant-based Consumer Packaged Goods, leveraging decades of experience in Controlled Environment Agriculture [5] - The company operates one of the largest cannabis operations globally, with 2.2 million square feet of greenhouse production in Canada, and is recognized as a low-cost producer with high-quality products [6] Product Innovation - The one-way aroma valve is pressure-activated, enabling the release of the flower's scent when squeezed, while preventing air and contaminants from entering the package, enhancing the consumer experience [2][3] - This innovation follows the introduction of window packaging, furthering the mission to make cannabis shopping more accessible and informative [3][4] Market Expansion - Village Farms is targeting international cannabis opportunities, exporting medical cannabis to markets such as Germany, the UK, Israel, Australia, and New Zealand, and expanding its export business [7] - The company plans to enter the US THC market, utilizing its Texas-based greenhouse assets for future growth [8]

Core Viewpoint - Tilray Brands has seen a 20% increase in stock value this year, marking a significant turnaround after years of decline, driven by renewed expectations for marijuana reform in the U.S. [1][2] Company Performance - Despite the current year's positive performance, Tilray's stock has plummeted 99% over the past seven years, with a market cap dropping from nearly $42 billion in 2018 to under $2 billion today [5]. - In the most recent fiscal year ending May 31, Tilray reported net revenue of $821.3 million, a 4% year-over-year increase, although its cannabis business declined by 9% [7]. Market Conditions - The Canadian cannabis market has become saturated, while the U.S. market remains inaccessible due to federal restrictions, limiting growth opportunities for Canadian producers like Tilray [6]. - The hope for U.S. cannabis reform, including potential rescheduling from Schedule I to Schedule III, has generated optimism among investors [10]. Valuation and Investment Appeal - Tilray's current price-to-sales ratio is below 1.8, suggesting it may be undervalued, making it an attractive option for investors looking for bargains [11]. - The diversification into alcohol has provided some stability, although the cannabis segment's performance remains weak [11].

Core Viewpoint - Jushi Holdings Inc. is set to report its financial results for the third quarter of 2025 on November 4, 2025, with a conference call scheduled to discuss these results [1][2]. Company Overview - Jushi Holdings Inc. is a vertically integrated cannabis company with a focus on building a multi-state portfolio of branded cannabis assets through acquisitions and competitive applications [3]. - The company aims to maximize shareholder value while delivering high-quality products across all levels of the cannabis ecosystem [3]. Event Details - The conference call for the third quarter 2025 financial results will take place on November 4, 2025, at 4:00 p.m. ET [2]. - Interested individuals can join the live call at 1-844-676-1334 (U.S. & Canada Toll-Free) and access the webcast on Jushi's Investor Relations website until December 5, 2025 [2].

Core Insights - Jeremy Szafron has joined Kitco News as an anchor and producer, bringing extensive experience in journalism, particularly in finance and current affairs [1][5] Background and Career Development - Jeremy began his journalism career in 2006 at CTV, initially focusing on entertainment before transitioning to business reporting, especially in mining and small-cap sectors [2] - He gained recognition for his macro-financial and market trends analysis, becoming a sought-after commentator on CTV Morning Live and CTV News Network [2] - A significant highlight of his career was covering the 2010 Vancouver Olympic Games, which led to the development of an online video news program for PressReader, a digital newsstand with 8,000 editions in 60 languages [3] Digital Media and Industry Contributions - In 2012, Jeremy launched The Green Scene Podcast, which quickly attracted over 400,000 subscribers, establishing him as a prominent voice in the cannabis industry [4] - Following this success, he created Investor Scene and Initiate Research, platforms that provide exclusive market insights and deal-flow opportunities in mining and Canadian small-cap markets [4] - Jeremy has also served as a market strategist and investor relations consultant for various publicly traded companies across mining, energy, consumer packaged goods, and technology sectors [5] Educational Background - Jeremy holds a BA in Journalism from Concordia University, which has supported his diverse career trajectory [5]

Core Insights - Glow Lifetech Corp. has announced significant commercial updates, including new key account wins and national distribution expansion, indicating continued commercial growth [1][4]. Group 1: Commercial Expansion - Glow has secured a new retail listing with One Plant Corp., expanding MOD™ products to over 60 retail locations across Ontario and Saskatchewan [2][3]. - The partnership with One Plant, a leading cannabis retailer in Canada, enhances Glow's retail expansion strategy and broadens MOD's consumer reach [3][4]. - Glow has successfully completed its first shipment into Saskatchewan, marking its initial entry into Western Canada with 10 product listings across its MOD™ and .decimal™ brands [7]. Group 2: Financial Health - To strengthen its balance sheet, Glow plans to issue up to 714,286 common shares to settle approximately $50,000 in outstanding debt at a deemed price of $0.07 per share [8]. - This debt settlement is aimed at preserving cash for working capital, reflecting the company's focus on improving financial health to support growth initiatives [8]. Group 3: Company Overview - Glow Lifetech is a Canadian biotechnology company specializing in nutraceutical and cannabinoid-based products, utilizing MyCell Technology® for enhanced bioavailability and effectiveness [11].

Core Insights - The stock market has shown strong returns over the past five years, but Tilray Brands has struggled to keep pace, indicating a significant underperformance in the cannabis industry [1][2]. Company Performance - Tilray has faced numerous challenges, including intense competition, legal barriers to loans, and stringent regulatory requirements, which have hindered its financial performance [2]. - The company has experienced a compound annual growth rate (CAGR) of -21.32% over the past five years, meaning an investment of $500 would now be worth $150.76, in stark contrast to an S&P 500 ETF investment that would be worth $1,031.74 due to a positive CAGR of 15.59% [3]. Future Outlook - There is some market optimism regarding potential changes in the legal landscape of the U.S. cannabis industry, and Tilray reported a rare net income in its latest quarterly update [4]. - Despite these developments, the company's historical performance and ongoing challenges suggest that the stock remains a high-risk investment, with concerns that future investments could yield even lower returns [5].